Vasculitis - I-Vasculitishttps://en.wikipedia.org/wiki/Vasculitis
I- I-Vasculitis (Vasculitis) iyiqembu lezinkinga ezibhubhisa imithambo yegazi ngokuvuvukala. I-Vasculitis ingahlukaniswa ngesizathu, indawo, uhlobo lomkhumbi noma ubukhulu bomkhumbi. Ukuhlolwa kwaselabhorethri kanye ne-skin biopsy kungase kudingeke ukuze kutholwe izimbangela. Ukwelashwa ngokuvamile kuqondiswe ekumiseni ukuvuvukala nokucindezela amasosha omzimba. Ngokuvamile, i-corticosteroids efana ne-prednisone isetshenziswa.

Ukuxilongwa
I-Vasculitis ekhawulelwe esikhumbeni ingase ibe ngcono ngokuhamba kwesikhathi. Kodwa-ke, ukuhlolwa kwegazi nomchamo kungenziwa ukuze kutholwe ukuphazamiseka kwesistimu noma kwe-autoimmune.

Ukwelashwa - Izidakamizwa ze-OTC
Uma i-vasculitis ikhawulelwe esikhumbeni ngaphandle kokuhlasela kwezinye izitho, kungasetshenziswa amafutha e-steroid.
#OTC steroid ointment
☆ Emiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine.
  • Okunye ukuphazamiseka kwesistimu (izifo ezizimele) ezibandakanya i-vasculitis kufanele zikhishwe.
  • Lesi yisithombe esijwayelekile se-vasculitis yomlenze. Ukuhlolwa komchamo kungenziwa ukuze kubhekwe ukungahambi kahle ekusebenzeni kwezinso.
  • Livedo vadculopathy
  • Purpura
  • Henoch schonlein purpura
References An aetiological & clinicopathological study on cutaneous vasculitis 22382191 
NIH
Of the 61 patients studied, hypersensitivity vasculitis (HSV) [23 (37.7%)] and Henoch Schonlein purpura (HSP) [16 (26.2%)] were the two most common forms. Systemic involvement was seen in 32 (52.45%) patients. Drugs were implicated in 12 (19.7%) cases, infections in 7 (11.4%) and connective tissue disorders in 4 (6.5%) cases. No association was seen between history of drug intake and tissue eosinophilia and also between histologically severe vasculitis and clinical severity.
 Leukocytoclastic Vasculitis 29489227 
NIH
Leukocytoclastic vasculitis wuhlobo lokuvuvukala kwesikhumba oluthinta imithambo yegazi emincane ezingqimbeni ezijulile zesikhumba. Kungenzeka ngaphandle kwesizathu esaziwayo noma kuxhunyaniswe nezifo, izimila, izifo ezizimele, noma imithi. Izimpawu ezijwayelekile zihlanganisa izindawo ezibomvu noma ezinsomi emilenzeni, ukubandakanyeka kwemikhumbi emincane, futhi cishe kumaphesenti angama-30 ezimweni, ezinye izingxenye zomzimba nazo ziyathinteka. Izimo eziningi ziphela zodwa emasontweni ambalwa kuya ezinyangeni. Ukwelashwa kuyehluka kuye ngokuthi kubi kangakanani, kusukela ekunciphiseni kancane kancane i-oral corticosteroids kuya ekusebenziseni ezinye izidakamizwa ezinciphisa ukuvuvukala ngaphandle kwama-steroid.
Leukocytoclastic vasculitis is a cutaneous, small-vessel vasculitis of the dermal capillaries and venules. This condition can be idiopathic or can be associated with infections, neoplasms, autoimmune disorders, and drugs. Key clinical features of leukocytoclastic vasculitis include palpable purpura on the lower extremity, small vessel involvement, and, in about 30 percent of individuals, extracutaneous involvement. Most cases of idiopathic cutaneous, small vessel vasculitis are self-limited with 90 percent of cases resolving in weeks to months of onset. Otherwise, treatment depends on the severity of disease and can range from an oral corticosteroid taper to various steroid-sparing immunosuppressive agents.